Dymon Asia Capital (Singapore)’s Definium Therapeutics DFTX Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$625K	Buy	+13,289	New	+$328K	0.03%	190

Other funds holding DFTX

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

PFA

Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s DFTX Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 13,289 shares worth $625K. The stake represents 0.03% of the portfolio and ranks #190 among its holdings.

74 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Dymon Asia Capital (Singapore) held 13,289 shares of Definium Therapeutics worth $625K as of Q2 2026.
Definium Therapeutics was a new Dymon Asia Capital (Singapore) position in Q2 2026.
Definium Therapeutics made up 0.03% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #190 holding.
74 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.